The treatment principles for Wilms' tumor involve various methods such as surgery, radiotherapy, and chemotherapy, which can cure the majority of children, even those with metastases, and achieve good effects. Since Wilms' tumor is sensitive to radiotherapy and chemotherapy, the combination of surgery with radiotherapy and chemotherapy can significantly improve the survival rate after surgery. For larger tumors, preoperative radiotherapy can reduce the tumor size, facilitating surgery, and vincristine can be used for preoperative preparation. Comprehensive treatment of Wilms' tumor for 2 years has a survival rate of 60% to 94%, and no recurrence within 2 to 3 years is considered cured. Bilateral Wilms' tumors can be treated with bilateral tumor resection, supplemented by radiotherapy and chemotherapy. The prognosis for adult Wilms' tumors is poorer, and the chemotherapy methods are similar to those for children.
One, Surgical Treatment
1. Early nephrectomy is performed through the abdominal route, and the Chevron incision is a good method for removing the kidney. The abdomen needs to be completely exposed, and special attention should be paid to the affected kidney, the opposite kidney, local areas, and paraaortic lymph nodes. The uninvolved kidney needs to be carefully palpated and explored, and the renal fascia needs to be incised to observe for metastatic foci. If there are metastatic foci, they should be removed or a partial nephrectomy should be performed. Before ligating the renal pedicle, the renal vein needs to be palpated to exclude the presence of tumor thrombi. In addition, avoid causing tumor rupture during the decompression. Tumor dissemination can be prevented by total abdominal treatment to prevent local recurrence in the abdomen. A total resection of the affected kidney, renal fascia, ipsilateral adrenal gland, and local lymph nodes is performed.
2. If the tumor is adherent to adjacent organs such as the spleen, tail of the pancreas, or lumbar muscle, it can be removed together with the tumor. If the tumor invades important organs such as the duodenum, pancreas, or mesenteric root, then surgery can only be determined after biopsy.
Two, Radiotherapy
Wilms' tumor is a radioresponsive tumor, and radiotherapy added after surgery can improve the efficacy, but it is rarely done before surgery.
Three, Chemotherapy
Chemotherapy has a significant effect on improving the survival rate of Wilms' tumor. Actinomycin D and Vincristine are both effective drugs. Chemotherapy can reduce the size of the tumor, reduce lung metastasis, and improve survival rate. The most sensitive drugs are Vincristine and Actinomycin D, and the combined effect of the two drugs is better. Doxorubicin (Adriamycin) and Cyclophosphamide can also be used. The dose of Actinomycin D is 15μg/(kg·d), for a total of 5 days, and the ideal dose can be 1.2mg/m2 every 3 weeks. Repeat at the 6th week and 3 months. After that, repeat every 3 months until the 15th month. Side effects include nausea, vomiting, diarrhea, stomatitis, alopecia, and bone marrow suppression.
1. Vincristine: 1.5mg/m2, once a week, for a total of 8 to 10 times, and then repeated before and after the Actinomycin D course for 1 week. Toxic reactions such as peripheral nerve damage, disappearance of deep reflexes of tendons, alopecia, and bone marrow suppression of red blood cell production may occur.
2. Cyclophosphamide: 10mg/(kg·d), for a total of 3 days, repeated once every 6 weeks.
3. Doxorubicin (Adriamycin): 20mg/m2, once a day, for a total of 3 days, repeated every 3 months alternately with Actinomycin D. In addition to having similar side effects and toxic effects as Actinomycin D, it also has toxic effects on the heart.
Four, Treatment of Metastatic Foci
1. Local radiation therapy of 12Gy for lung metastasis and 30Gy for liver metastasis, for 3 to 4 weeks, and combined chemotherapy with three drugs is required. Bilateral renal embryonal tumors can occur simultaneously or sequentially, but it is generally not recommended to perform renal transplantation after bilateral nephrectomy, as the prognosis is not better than simple tumor resection combined with radiotherapy and chemotherapy.
2. Before treatment, a comprehensive understanding of the specificity and prognostic factors of the tumor is necessary. Formulate an appropriate treatment plan based on the specific case to improve the efficacy of treatment. It is also important to prevent unnecessary and harmful over-treatment during the treatment process. Regular follow-up is essential after the main treatment is completed.
3. The comprehensive therapy of surgery combined with chemotherapy and radiotherapy has been recognized as a treatment method. However, how to combine and apply the dosage and course of treatment to achieve the goal of minimizing harm and maximizing efficacy is worthy of in-depth study.
4. Nephrectomy is the main treatment method, and there is often a small amount of blood loss during the operation. For large tumors, especially those involving the inferior vena cava, there is a risk of massive bleeding. Therefore, preoperative preparation should include central venous catheter insertion and monitoring, and blood volume can be rapidly replenished if necessary. Radial artery catheter insertion and monitoring can allow for timely blood gas analysis, and a catheter should be placed during the operation and urine output monitored postoperatively.
5. The tumor is fragile and prone to rupture, so the abdominal incision must have a wide exposure to facilitate the exposure of the renal vein and exploration of other tumor lesions. The best approach is a transverse incision from the axillary front of the 12th rib to the opposite edge. When resecting a large tumor, it may be necessary to add a chest extension incision to make the surgery easier and safer. A thorough exploration of the abdominal cavity is required, which may involve lymph node and/or liver metastasis. Biopsy should be performed on suspicious lymph nodes, and metal clips should be used for marking. The opposite kidney should be carefully inspected and palpated.
6. The traditional requirement for early ligation of the renal vein during surgery is believed to reduce the risk of pulmonary tumor embolism. However, according to various data, the timing of venous ligation does not affect the prognosis. If the renal vein is ligated before the renal artery, the outflow blockage occurs before the inflow blockage, resulting in congestion and swelling of the tumor, increased fragility, and venous rupture of the perirenal tumor. Therefore, when technically feasible, the artery should be blocked early to reduce the size and fragility of the tumor, making it easier to operate. When the tumor is large, it is impossible to expose the renal vein first; it is necessary to wait for the four sides to be freed and reach the renal hilum from the side. If a thoracoabdominal combined incision is made, it is more convenient.
7. When encountering rare cases, large tumors and/or patients with poor conditions, in order to make the tumor shrink before surgery for easy and safe resection, a course of vinblastine or radiotherapy or renal artery embolization can be applied. However, before the preoperative treatment plan is used, the survival rate is not improved, and there are the following disadvantages of preoperative treatment: low-dose chemotherapy can also destroy the tissue structure of the tumor, so it is not possible to stage, resulting in inappropriate treatment plans; misdiagnosis can occur. In some cases of abdominal masses, laparotomy proves that it is not Wilms' tumor; infants with stage I tumors receive inappropriate preoperative treatment.